Revenue from Contracts with Customers (Tables)

12 Months Ended

Dec. 31, 2020

Revenue from Contract with Customer [Abstract]

Schedule of Revenues by Type of Service

The Company provides diagnostic test products, laboratory services to hospitals, clinical laboratories and other healthcare provider customers, and enters into collaboration agreements with government agencies and healthcare providers. The revenues by type of service consist of the following:

	Years Ended December,
	2020		2019
Product sales	$	2,704,364	$	2,168,179
Laboratory services		167,736		5,435
Collaboration revenue		1,342,341		1,325,000
Total revenue	$	4,214,441	$	3,498,614

Revenues by geography are as follows:

	Years Ended December,
	2020		2019
Domestic	$	1,917,367	$	3,322,615
International		2,297,074		175,999
Total revenue	$	4,214,441	$	3,498,614

Summary of Changes in Deferred Revenue

Deferred revenue

Changes in deferred revenue for the period were as follows:

Balance at December 31, 2019	$	9,808
Acquired deferrals from Curetis		829,275
Revenue recognized in the current period from the amounts in the beginning balance		—
Revenue recognized in the current period from the amounts acquired from Curetis		(870,114	)
Effect of foreign exchange rates		40,839
Balance at December 31, 2020	$	9,808